Literature DB >> 19293952

Clinical trial design: horses for courses.

John R Geddes1.   

Abstract

Entities:  

Year:  2009        PMID： 19293952      PMCID： PMC2652895          DOI： 10.1002/j.2051-5545.2009.tb00201.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  21 in total

1.  Can it work? Does it work? Is it worth it? The testing of healthcareinterventions is evolving.

Authors:  B Haynes
Journal:  BMJ       Date:  1999-09-11

2.  Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).

Authors:  D L Sackett
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

3.  A meta-analysis of the efficacy of second-generation antipsychotics.

Authors:  John M Davis; Nancy Chen; Ira D Glick
Journal:  Arch Gen Psychiatry       Date:  2003-06

4.  Generating evidence to inform policy and practice: the example of the second generation "atypical" antipsychotics.

Authors:  John Geddes
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

5.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

Review 6.  Large-scale randomized evidence: large, simple trials and overviews of trials.

Authors:  R Peto; R Collins; R Gray
Journal:  J Clin Epidemiol       Date:  1995-01       Impact factor: 6.437

7.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

8.  Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials.

Authors:  J Geddes; G Goodwin
Journal:  Br J Psychiatry       Date:  2001-06       Impact factor: 9.319

Review 9.  Randomized controlled trials for schizophrenia: study designs targeted to distinct goals.

Authors:  T Scott Stroup; John R Geddes
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

10.  Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

Authors:  Carol E Koro; Donald O Fedder; Gilbert J L'Italien; Sheila S Weiss; Laurence S Magder; Julie Kreyenbuhl; Dennis A Revicki; Robert W Buchanan
Journal:  BMJ       Date:  2002-08-03
View more
  2 in total

1.  Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years.

Authors:  Xu Liu; Yuan Zhang; Ling-Long Tang; Quynh Thu Le; Melvin L K Chua; Joseph T S Wee; Nancy Y Lee; Brian O'Sullivan; Anne W M Lee; Ying Sun; Jun Ma
Journal:  JAMA Oncol       Date:  2018-08-01       Impact factor: 31.777

2.  The Landscape of Clinical Trials Evaluating the Theranostic Role of PET Imaging in Oncology: Insights from an Analysis of ClinicalTrials.gov Database.

Authors:  Yu-Pei Chen; Jia-Wei Lv; Xu Liu; Yuan Zhang; Ying Guo; Ai-Hua Lin; Ying Sun; Yan-Ping Mao; Jun Ma
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.